GlaxoSmithKline reported GBP0.55 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 0.55 0.53 0.55 Oct/28
FY2026Q2 Jun/2026 0.51 0.45 0.47 Jul/29
FY2026Q1 Mar/2026 0.43 0.43 0.45 Apr/29
FY2025Q4 Dec/2025 0.26 0.24 0.23 Feb/04
FY2025Q3 Sep/2025 0.55 0.47 0.50 Oct/29




Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Alcon AG USD 0.91 0.07 Sep/2026
Almirall EUR 0.2 0.13 Jun/2026
Amgen USD 6.45 0.16 Sep/2026
argenx SE USD 7.8 1.36 Sep/2026
AstraZeneca USD 2.79 0.16 Sep/2026
Bayer EUR 0.31 0.64 Sep/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Fresenius EUR 0.86 0.03 Sep/2026
Fresenius Medical Care EUR 1.11 0.01 Sep/2026
Genmab DKK 5.43 4.6 Jun/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Glaxosmithkline GBP 0.76 0.14 Sep/2026
GRIFOLS EUR 0.3 0.07 Sep/2026
Hikma Pharmaceutical USD 0.65 0.12 Dec/2025
Lakefront Biotherapeutics EUR -0.23 0.03 Sep/2026
Lonza CHF 6.07 1.92 Jun/2025
Merck EUR 2.04 2.58 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Orion EUR 1.19 0.19 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Philips EUR 0.35 0.14 Sep/2026
Recordati EUR 0.66 0.01 Sep/2026
Regeneron Pharmaceuticals USD 20.07 5.78 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sanofi EUR 3.55 1.46 Sep/2026
Smith & Nephew USD 0.47 0.12 Jun/2026
UCB EUR 5.65 3.21 Dec/2025